JPMorgan Chase & Co. Reiterates Neutral Rating for Bath & Body Works (NYSE:BBWI)

Bath & Body Works (NYSE:BBWI)‘s stock had its “neutral” rating reiterated by analysts at JPMorgan Chase & Co. in a report issued on Monday,Benzinga reports. They presently have a $26.00 price objective on the stock. JPMorgan Chase & Co.‘s price target points to a potential upside of 0.51% from the stock’s previous close.

A number of other analysts also recently weighed in on BBWI. Barclays upped their price target on shares of Bath & Body Works from $30.00 to $32.00 and gave the stock an “equal weight” rating in a report on Friday, August 29th. Wall Street Zen downgraded shares of Bath & Body Works from a “buy” rating to a “hold” rating in a research note on Saturday, August 9th. Weiss Ratings restated a “hold (c-)” rating on shares of Bath & Body Works in a research report on Saturday, September 27th. Morgan Stanley cut their target price on shares of Bath & Body Works from $19.00 to $18.00 and set an “overweight” rating on the stock in a research report on Friday, September 12th. Finally, Citigroup cut their target price on shares of Bath & Body Works from $42.00 to $40.00 and set a “buy” rating on the stock in a research report on Tuesday, August 19th. Eleven investment analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $38.15.

Bath & Body Works Stock Up 0.8%

Shares of NYSE:BBWI opened at $25.87 on Monday. The company’s 50 day moving average price is $28.42 and its two-hundred day moving average price is $29.46. Bath & Body Works has a 12-month low of $24.93 and a 12-month high of $41.87. The firm has a market cap of $5.33 billion, a PE ratio of 7.68, a PEG ratio of 0.88 and a beta of 1.52.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share for the quarter, hitting analysts’ consensus estimates of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion during the quarter, compared to the consensus estimate of $1.55 billion. During the same quarter in the prior year, the firm posted $0.37 EPS. The firm’s quarterly revenue was down .8% on a year-over-year basis. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. On average, research analysts expect that Bath & Body Works will post 3.3 EPS for the current year.

Hedge Funds Weigh In On Bath & Body Works

Hedge funds have recently bought and sold shares of the company. Stonehage Fleming Financial Services Holdings Ltd bought a new position in Bath & Body Works during the second quarter worth $33,000. SVB Wealth LLC bought a new stake in Bath & Body Works in the first quarter valued at $35,000. Geneos Wealth Management Inc. increased its stake in Bath & Body Works by 217.7% in the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock valued at $35,000 after purchasing an additional 801 shares in the last quarter. Parallel Advisors LLC increased its stake in Bath & Body Works by 63.3% in the second quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after purchasing an additional 481 shares in the last quarter. Finally, Golden State Wealth Management LLC increased its position in shares of Bath & Body Works by 94.7% during the first quarter. Golden State Wealth Management LLC now owns 1,320 shares of the company’s stock worth $40,000 after acquiring an additional 642 shares in the last quarter. Institutional investors own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.